Keywords: positive, data, dyax, angioedema, drug, corp, usa

Positive data for Dyax' angioedema drug

Article | 17 January 2005

Print This

Dyax Corp of the USA has reported promising interim results from a Phase II clinical trial of its hereditary angioedema ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in